127 related articles for article (PubMed ID: 27389087)
21. EphB1 and Ephrin-B, new potential biomarkers for squamous cell/adenosquamous carcinomas and adenocarcinomas of the gallbladder.
Yuan Y; Yang ZL; Miao XY; Liu ZR; Li DQ; Zou Q; Li JH; Liang LF; Zeng GX; Chen SL
Asian Pac J Cancer Prev; 2014; 15(3):1441-6. PubMed ID: 24606480
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathological and prognostic significance of SHP2 and Hook1 expression in patients with thyroid carcinoma.
Cao J; Huang YQ; Jiao-Sun ; Lan XB; Ge MH
Hum Pathol; 2018 Nov; 81():105-112. PubMed ID: 29953894
[TBL] [Abstract][Full Text] [Related]
23. ILK and PRDX1 are prognostic markers in squamous cell/adenosquamous carcinomas and adenocarcinoma of gallbladder.
Li J; Yang ZL; Ren X; Zou Q; Yuan Y; Liang L; Chen M; Chen S
Tumour Biol; 2013 Feb; 34(1):359-68. PubMed ID: 23065574
[TBL] [Abstract][Full Text] [Related]
24. PKM2 and ACVR 1C are prognostic markers for poor prognosis of gallbladder cancer.
Li J; Yang Z; Zou Q; Yuan Y; Li J; Liang L; Zeng G; Chen S
Clin Transl Oncol; 2014 Feb; 16(2):200-7. PubMed ID: 23793810
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of metastasis associated in colon cancer 1 (MACC1) expression in patients with gallbladder cancer.
Chen L; Wang J; Fu L; Zhang B; Zhang H; Ye B
J Cancer Res Ther; 2014; 10(4):1052-6. PubMed ID: 25579553
[TBL] [Abstract][Full Text] [Related]
26. Positive ALDH1A3 and negative GPX3 expressions are biomarkers for poor prognosis of gallbladder cancer.
Yang ZL; Yang L; Zou Q; Yuan Y; Li J; Liang L; Zeng G; Chen S
Dis Markers; 2013; 35(3):163-72. PubMed ID: 24167362
[TBL] [Abstract][Full Text] [Related]
27. ACO2 and ANPEP as novel prognostic markers for gallbladder squamous cell/adenosquamous carcinomas and adenocarcinomas.
Liu Z; Yang Z; Xiong L; Li D; Zou Q; Yuan Y
Int J Clin Oncol; 2020 Jul; 25(7):1346-1355. PubMed ID: 32249333
[TBL] [Abstract][Full Text] [Related]
28. Expression of CDC6 and GDF-9 and their clinicopathological significances in benign and malignant lesions of the gallbladder.
Shu GS; Yang LP; Yang ZL; Jiang S
Cancer Biomark; 2012; 11(2-3):107-14. PubMed ID: 23011157
[TBL] [Abstract][Full Text] [Related]
29. Clinical Significance of CBS and CCL21 in Gallbladder Adenocarcinomas and Squamous Cell/Adenosquamous Carcinomas.
Li D; Yang Z; Liu Z; Zou Q; Yuan Y
Appl Immunohistochem Mol Morphol; 2020 Feb; 28(2):103-110. PubMed ID: 32044878
[TBL] [Abstract][Full Text] [Related]
30. Heparanase expression in gallbladder carcinoma and its correlation to prognosis.
Wu W; Pan C; Yu H; Gong H; Wang Y
J Gastroenterol Hepatol; 2008 Mar; 23(3):491-7. PubMed ID: 17524042
[TBL] [Abstract][Full Text] [Related]
31. Expressions of farnesoid X receptor and myeloid cell leukemia sequence 1 protein are associated with poor prognosis in patients with gallbladder cancer.
Wang W; Yin X; Li G; Yi J; Wang J
Chin Med J (Engl); 2014; 127(14):2637-42. PubMed ID: 25043081
[TBL] [Abstract][Full Text] [Related]
32. DNA-PKcs and Ku70 are predictive markers for poor prognosis of patients with gall bladder malignancies.
Ren F; Yang ZL; Tan X; Liu D; Zou Q; Yuan Y; Li J; Liang L; Zeng G; Chen S
Appl Immunohistochem Mol Morphol; 2014; 22(10):741-7. PubMed ID: 25046228
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical study of Dicer and Drosha expression in the benign and malignant lesions of gallbladder and their clinicopathological significances.
Shu GS; Yang ZL; Liu DC
Pathol Res Pract; 2012 Jul; 208(7):392-7. PubMed ID: 22658478
[TBL] [Abstract][Full Text] [Related]
34. Prognostic Value of the Stem Cell Markers Epcam and CD133 Expression Of Gallbladder Adenocarcinoma.
Jiang S; Pei L; Yang ZL; Liu G
Hepatogastroenterology; 2014 May; 61(131):574-9. PubMed ID: 26176038
[TBL] [Abstract][Full Text] [Related]
35. Expression of N-myc downstream-regulated gene 1 in primary gallbladder carcinoma and its correlation with clinicopathological features and clinical outcome.
Zhang SB; Song SP; Li B; Zhou YS; Zhang YD
Med Oncol; 2012 Sep; 29(3):1866-72. PubMed ID: 21735144
[TBL] [Abstract][Full Text] [Related]
36. Expression of epithelial cell adhesion molecule in gallbladder carcinoma and its correlation with clinicopathologic variables.
Prince S; Zeidman A; Dekel Y; Ram E; Koren R
Am J Clin Pathol; 2008 Mar; 129(3):424-9. PubMed ID: 18285265
[TBL] [Abstract][Full Text] [Related]
37. Expression of p63, TTF-1 and Maspin in Non-Small Cell Lung Carcinoma and Their Effect on the Prognosis and Differential Diagnosis.
Yaman B; Nart D; Ekren PK; Çok G; Veral A
Turk Patoloji Derg; 2015; 31(3):163-74. PubMed ID: 26456962
[TBL] [Abstract][Full Text] [Related]
38. Correlation of decreased expression of PHLDA1 protein with malignant phenotype of gastric adenocarcinoma.
Zhao P; Lu Y; Liu L
Int J Clin Exp Pathol; 2015; 8(5):5230-5. PubMed ID: 26191222
[TBL] [Abstract][Full Text] [Related]
39. MTDH and EphA7 are markers for metastasis and poor prognosis of gallbladder adenocarcinoma.
Liu DC; Yang ZL
Diagn Cytopathol; 2013 Mar; 41(3):199-205. PubMed ID: 21964981
[TBL] [Abstract][Full Text] [Related]
40. Identification of PEG10 and TSG101 as carcinogenesis, progression, and poor-prognosis related biomarkers for gallbladder adenocarcinoma.
Liu DC; Yang ZL; Jiang S
Pathol Oncol Res; 2011 Dec; 17(4):859-66. PubMed ID: 21455631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
